Market Insights Snapshot
Looking at the performance of Kikoko across various categories in California, there are some noticeable trends. In the Beverage category, Kikoko has seen a steady improvement in its ranking, moving from 20th in August to 16th in November 2023. This indicates a growing popularity of Kikoko's beverages among Californian consumers. However, the Edible category tells a slightly different story. Despite a slight improvement from 32nd to 29th rank between August and November, Kikoko's rank in this category remains relatively low compared to other categories.
On the other hand, Kikoko's Capsules have been performing exceptionally well in California. Maintaining a consistent top 5 ranking from August to November 2023, with a peak at 3rd place in October, this category is clearly a strong performer for Kikoko. However, the Tincture & Sublingual category seems to be an area of concern. The brand did not make it to the top 20 in August and November, and only managed to secure the 54th position in September. This suggests a need for improvement in this category.
Competitive Landscape
In the competitive landscape of the Capsules category in California, Kikoko has maintained a consistent presence, though it has seen some fluctuations in rank. In August and September 2023, Kikoko held the 4th position, rose to 3rd in October, and then returned to the 4th spot in November. This indicates a strong competition with other brands like ABX / AbsoluteXtracts and Breez, which consistently ranked higher. Notably, Breez secured the 2nd position throughout the period, indicating a higher sales performance. On the other hand, brands like Buddies and Emerald Bay Extracts ranked below Kikoko, showing a lower sales performance. The data suggests a competitive but stable market for Kikoko, with potential for growth and improvement in its ranking.
Notable Products
In November 2023, Kikoko's best-selling product was the XTabs - Sativa High Dose Tablets 20-Pack (1000mg) with a total of 6976 units sold. This product consistently ranked first in sales, except for September when it was briefly overtaken by the XTabs - Indica High Dose Tablets 20-Pack (1000mg), which held the second position in November. The third place was occupied by XTabs - Hybrid High Dose Tablets 20-Pack (1000mg), maintaining its position from previous months. The fourth and fifth rankings were held by the edibles Little Helpers - CBN/THC/Melatonin 3:2:1 Sleep Mints 20-Pack (60mg CBN, 40mg THC, 20mg Melatonin) and Little Helpers - CBD/THC 2:1 Calm Mints 20-Pack (100mg CBD, 50mg THC) respectively. Despite minor fluctuations, the rankings remained relatively stable over the last four months.